OTCMKTS:PHMMF Pharma Mar (PHMMF) Stock Price, News & Analysis → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free PHMMF Stock Alerts $31.15 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$31.15▼$31.1550-Day Range$26.85▼$31.1552-Week Range$26.85▼$46.26Volume75 shsAverage Volume8 shsMarket Capitalization$561.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Pharma Mar alerts: Email Address Ad TradingTipsBuy these “two-bagger” stocksWe’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today! About Pharma Mar Stock (OTCMKTS:PHMMF)Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14, which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trial for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trial for treating solid tumors; Tivanisiran, which is in Phase III clinical trial for the treatment of dry eye disease; and SYL1801 that is in phase II clinical trial for treating macular degeneration. In addition, it engages in the development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.Read More PHMMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHMMF Stock News HeadlinesMay 18, 2024 | markets.businessinsider.comRevolutionizing Pharmaceutical Manufacturing: The Visionary Work of Tejesh MarsaleMay 16, 2024 | msn.comTransforming Pharmaceutical Manufacturing: The Visionary Work of Tejesh MarsaleMarch 18, 2024 | markets.businessinsider.comPharming Group’s Strong Performance and Growth Prospects Justify Buy RatingMarch 16, 2024 | newsweek.comMar-a-lagoMarch 7, 2024 | markets.businessinsider.comPersica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back painFebruary 17, 2024 | investing.comPharma Mar SAU (PHMR)February 1, 2024 | investorplace.comPfizer’s 2024 Comeback: A Dividend Gem in the Pharma MarketJanuary 9, 2024 | msn.comTwo new databases combine computer science and pharmaceutical researchNovember 29, 2023 | msn.comFirst West Africa Healthcare, Lab, & Pharma Week 2024 To Hold In NigeriaNovember 6, 2023 | morningstar.comPharma Mar SA PHMOctober 28, 2023 | markets.businessinsider.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024July 15, 2023 | barrons.comPharma Mar S.A.June 21, 2023 | forbes.comYifan PharmaceuticalJune 6, 2023 | finance.yahoo.comPHM.MC - Pharma Mar, S.A.April 22, 2023 | msn.comNEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy RecommendationMarch 27, 2023 | marketwatch.comPharmaceutical Excipients Market Top Players By 2031March 25, 2023 | news.yahoo.comPharmaceutical company to open in McHenryMarch 24, 2023 | markets.businessinsider.comInnate Pharma (IPHA) Receives a Buy from H.C. WainwrightMarch 16, 2023 | bizjournals.comBig Pharma companies back new startup out of Mass General BrighamNovember 9, 2022 | markets.businessinsider.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023October 10, 2022 | yahoo.comEuropean Commission suspects pharma group Teva broke antitrust rulesAugust 30, 2022 | apnews.comPharmacists Database List of Emails, Phone Numbers, Contact InformationJanuary 11, 2022 | finance.yahoo.comLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsNovember 11, 2021 | finanznachrichten.dePharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanOctober 28, 2021 | news.yahoo.comSpain's PharmaMar posts 58% drop in 9-mth profit despite higher revenuesSee More Headlines Receive PHMMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:PHMMF Previous SymbolNASDAQ:PHMMF CUSIPN/A CIKN/A Webwww.pharmamar.com Phone(491) 846-6000Fax34-91-846-6001Employees509Year Founded1986Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.14 Current Ratio2.63 Quick Ratio2.22 Sales & Book Value Annual Sales$171.15 million Price / SalesN/A Cash Flow$0.41 per share Price / Cash Flow75.21 Book Value$11.62 per share Price / Book2.68Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.26 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Jose Maria Fernandez Sousa-Faro Ph.D.Founder, Executive Chairman, CEO & PresidentMr. Pedro Francisco Fernandez PuentesExecutive DirectorMr. Juan Carlos-Torres Carretero (Age 75)Founder Ms. María Luisa de Francia CaballeroChief Financial OfficerMr. José Luis Moreno Martinez-LosaDirector of Capital Markets & Investor RelationsMr. Juan Gomez PulidoGeneral Counsel & Secretary of the Board of DirectorsMs. Sandra Llamera SanchezGlobal Compliance HeadMs. Lara VadilloCommunication DirectorMs. Belén Sopesén Veramendi Ph.D.Director of Corporate DevelopmentMr. Luis Rupérez CuencaDirector of Human Resources & ITMore ExecutivesKey CompetitorsJapan Steel WorksOTCMKTS:JPSWYEro CopperNYSE:EROSafestoreOTCMKTS:SFSHFEro CopperOTCMKTS:ERRPFMitie GroupOTCMKTS:MITFYView All Competitors PHMMF Stock Analysis - Frequently Asked Questions How have PHMMF shares performed in 2024? Pharma Mar's stock was trading at $46.26 at the beginning of 2024. Since then, PHMMF shares have decreased by 32.7% and is now trading at $31.15. View the best growth stocks for 2024 here. How do I buy shares of Pharma Mar? Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PHMMF) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma Mar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.